Despite recognition of the fundamental role of zinc (Zn 2+ ) for growth and proliferation, 9 mechanisms of how Zn 2+ deficiency arrests these processes remain enigmatic. We induced 10 subtle intracellular Zn 2+ perturbations and tracked asynchronously cycling cells throughout 11 division using fluorescent reporters, high throughput microscopy, and quantitative analysis. We 12 found that Zn 2+ deficiency induces quiescence and Zn 2+ resupply stimulates cell-cycle reentry. 13 By monitoring single cells after Zn 2+ deprivation, we found that depending on where cells were 14 in the cell cycle, they either went quiescent or entered the cell cycle but stalled in S phase. 15 Stalled cells were defective in DNA synthesis and had increased DNA damage levels, suggesting 16 a role for Zn 2+ in maintaining genome integrity. Finally, we found that Zn 2+ deficiency-induced 17 quiescence does not require the cell-cycle inhibitor p21. Overall, our study provides new 18 insights into when Zn 2+ is required during the mammalian cell cycle and the consequences Zn 2+ 19 deficiency. 20 21 of Zn 2+ deficiency are diverse and can be organism specific, one defining feature is universal: 1 Zn 2+ deficient cells fail to divide and proliferate normally, leading to organismal growth 2 impairment (5). Despite recognition of the fundamental role of Zn 2+ for proliferation, the 3 mechanisms of how Zn 2+ deficiency leads to cell-cycle arrest at the cellular and molecular level 4 remain poorly defined.
Introduction
Zinc (Zn 2+ ) is the second most abundant transition metal in biology and is widely 23 recognized as an essential micronutrient to all living organisms (1) . Zn 2+ was first reported to be 24 essential for growth of Aspergillus niger in 1869 and subsequently demonstrated for plants, 25 animals, and humans (2) with the first cases of human Zn 2+ deficiency and the associated growth 26 and developmental disorders described in 1961 (3) . Zn 2+ deficiency has since been recognized 27 as a global health problem, and the World Health Organization (WHO) estimates a staggering 28 one third of the world's population does not consume adequate Zn 2+ and is therefore at risk for 29 associated side effects and comorbidities 30 (https://www.who.int/whr/2002/chapter4/en/index3.html) (4) . While the clinical manifestations resupply stimulates synchronized cell cycle reentry. By following the entry of single cells into 23 quiescence over time after Zn 2+ deprivation, we found that depending on where cells were in the 24 cell cycle, they either entered quiescence after mitosis, or entered the cell cycle but stalled in S 25 phase. Further, we determined that cells stalled in S phase were defective in DNA synthesis and 26 had increased levels of DNA damage, consistent with previous bulk analysis studies (31) (32) (33) ) 27 suggesting a critical role for Zn 2+ in maintaining genome integrity during replication. Finally, 28 we found that Zn 2+ deficiency-induced quiescence does not require p21, suggesting a mechanism 29 distinct from spontaneous quiescence (16, 19) , and follows a different pattern than mitogen studying the effect of Zn 2+ -deficiency on cell proliferation (38) (39) (40) . Even at the low end of 23 TPEN concentrations reported in the literature (3 µM) , greater than 70% cell death was observed 24 at 24 hrs, compared to 3 µM TPA with ~ 15 % cell death. When noted, an even milder ZD 25 condition of 2 µM TPA was used and this condition resulted in only ~ 1% cell death 26 (Supplementary Figure S2 ). Our results are consistent with several studies that found TPEN 27 induces apoptosis (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) . 28 To determine how defined Zn 2+ media conditions influenced intracellular labile Zn 2+ 29 levels in the cytosol, we created an MCF10A cell line stably expressing a genetically encoded 30 FRET-based sensor for Zn 2+ (ZapCV2 (41) ), grew the cells in ZD, MM, and ZR media, and measured the resting FRET ratio in individual cells. Cells grown in ZD had a significantly lower 1 average FRET ratio than cells grown in MM, while those grown in ZR conditions had 2 significantly higher FRET ratios ( Figure 1A) . The FRET ratio correlates with the amount of 3 labile Zn 2+ in the cytosol, and in situ calibration suggests the respective Zn 2+ levels are 4 approximately 1, 80, and 210 pM for ZD, MM, and ZR media, respectively (Supplementary 5 Figure S3 ), indicating that exogenous nutritional Zn 2+ levels positively influence intracellular 6 free Zn 2+ levels. 7 To assess how the three nutritional Zn 2+ regimes influenced cellular proliferation, we 8 counted cells as a function of time. Naturally cycling cells expressing H2B-mCherry were 9 imaged for 60 hrs and cells in each frame were segmented and counted using a custom 10 automated analysis as described in the Supplementary Note. ZD growth conditions exhibited 11 significantly reduced cell counts over time compared to MM and ZR conditions, with cell 12 proliferation effectively halted after about 15 hrs ( Figure 1B ). Cells grown in ZR conditions 13 reached higher cell counts, demonstrating that increased Zn 2+ in the media promotes cellular 14 proliferation. 15 Having established that our Zn 2+ deficient conditions did not result in increased cell 16 death, the decreased cell counts in ZD conditions could result either from a longer time between 17 cell divisions, or an increased fraction of cells that enter a non-proliferative quiescent state. To 18 differentiate these possibilities, we tracked individual cells over time and counted the number of 19 mitosis events and the time between these events. Mitosis events were identified by a 20 combination of the change in intensity of H2B-mCherry and change in size of the nucleus as 21 described in the Supplementary Note. The number of mitosis events in ZD media decreased over 22 time with few mitosis events detected after about 15 hrs ( Figure 1C ). Cells grown in MM and 23 ZR conditions underwent mitosis events throughout the observation period, with a comparable 24 inter-mitotic time (peaking around 13 hrs, Supplementary Figure S4 ). The inter-mitotic time 25 could not be measured in ZD media because few cells underwent multiple rounds of cell 26 division. Resupply of Zn 2+ by adding back either MM or ZR media after 24 hrs in ZD conditions 27 restored cell proliferation ( Figure 1B, 1C) , revealing that the cells were cell-cycle competent.
28
Combined, these results suggest that mild Zn 2+ deprivation reduces cell proliferation, not by 29 induction of cell death, but by inducing cell cycle arrest.
Mild Zn 2+ deficiency induces cellular quiescence and stalling of the cell cycle at an
1 intermediate CDK2 activity 2 To further examine how ZD conditions halted cell division and characterize the state of 3 cells in ZD media, we examined single cell fate using a fluorescent reporter of CDK2 activity 4 (16) . Following cell division, CDK2 activity is low and the fluorescent reporter is localized in 5 the nucleus, but as the cell cycle proceeds CDK2 activity increases and the reporter is 6 progressively translocated into the cytosol (16) . Thus, the ratio of cytosolic/nuclear fluorescence 7 can be used as a readout for CDK2 activity and serves a 'molecular timer' for progression 8 through the cell cycle. As described previously, CDK2 activity defines subpopulations of cells 9 with different cell fates in a population of naturally cycling cells (16, 17, 19, 42, 43) . When the 10 CDK2 ratio remains low after mitosis (CDK2 low ), a cell is classified as quiescent whereas when 11 CDK2 activity increases above a defined threshold within 4 hrs after mitosis (CDK2 inc ), a cell is 12 born committed to cell cycle entry ( Figure 2A ). A third classification has been observed, in 13 which a cell is born with low CDK2 activity (low CDK2 ratio) but eventually ramps up activity 14 and commits to the cell cycle (CDK2 emerge ). 15 To define how Zn 2+ availability in the media affects cell cycle commitment, we used an 16 MCF10A cell line stably expressing the fluorescent CDK2 reporter and H2B-mTurquoise2 and 17 imaged cells in ZD, MM or ZR media for 60 hrs. Individual cells were segmented, tracked, and 18 analyzed for CDK2 activity using a custom MATLAB pipeline (Supplementary Note). In Zn 2+ 19 sufficient media, cells cycled naturally throughout the observation window, as evidenced by the 20 observation of mitosis events, inter-mitotic time, and cyclical decrease in CDK2 activity after S4). When cell traces from each condition were aligned computationally to mitosis, we observed 23 all three cell fate classifications (CDK2 inc , CDK2 emerge , CDK2 low ) with a similar percentage in 24 each category in MM and ZR media (CDK2 inc 56% vs. 60%, CDK2 emerge 49% vs 41%, CDK2 low 25 17% vs 14% for MM and ZR, respectively). However, in ZD media the number of mitosis 26 events ceased after about 20 hrs, the CDK2 activity either stayed low or rose to an intermediate 27 level, and cells rarely underwent multiple rounds of the cell cycle ( Figure 2B ). Computational 28 alignment to mitosis and cell classification revealed that few cells were born with CDK2 activity 29 sufficient to commit to the next cell cycle (9% CDK2 inc ), a significant decrease compared to MM 30 and ZR, and there was a substantial increase in the percentage of cells with low CDK2 activity following mitosis CDK2 low (41%). One of the most striking differences between ZD and MM or 1 ZR conditions was the fate of cells that attempted to re-enter the cell cycle (i.e. whose CDK2 2 activity increased) following mitosis. As shown in Figure 2C , in ZD media CDK2 emerge cells 3 increased CDK2 activity after a period of transient quiescence but plateaued at an intermediate 4 CDK2 activity (a ratio of about 1.2), did not achieve maximal CDK2 activity, and failed to 5 divide. Similarly, CDK2 inc cells increased CDK2 activity to an intermediate level before they 6 dropped to a low level ( Figure 2C ). Analysis of mitosis events revealed that these cells did not 7 divide before entering the CDK2 low state. These results suggest a significant increase in the 8 number of cells that go quiescent after mitosis and the emergence of a new cell fate, where cells 9 attempt to re-enter the cell cycle but stall part-way through under conditions of Zn 2+ deficiency. 10 To further define how Zn 2+ deficiency influences cell fate and characterize the 11 consequences of the altered CDK2 activity profile in ZD cells, we examined a downstream 12 CDK2 substrate, retinoblastoma protein (Rb). When CDK2 levels are low, Rb binds to and 13 inhibits E2F family transcription factors, blocking cell cycle progression (44) . As CDK2 activity 14 increases, Rb gets hyper-phosphorylated which releases the inhibition, enabling E2F to 15 transcribe cell cycle genes. A previous study showed that cells born with elevated CDK2 16 activity also had hyper-phosphorylated Rb (pRb), as determined by immunofluorescence, 17 whereas cells born with CDK2 low had low levels of phosphorylated Rb (16) . We employed a 18 similar protocol to measure phosphorylated Rb and DNA content by Fluorescence Activated Cell 19 Sorting (FACS). After 24 hrs of growth in MM or ZR media, the majority of cells had hyper-20 pRb with either 2N, intermediate, or 4N DNA content, suggesting cells were actively cycling 21 through G1, S, G2, and M ( Figure 2D ). The small fraction of cells with hypo-pRb and 2N DNA 22 content, correspond to the small fraction of cells with CDK2 low and represent quiescent cells. 23 Treatment of cells with 2 M TPA for 24 hrs revealed that most cells had 2N DNA content and 24 hypo-pRb, consistent with most cells being in a quiescent state. However, some cells had hyper- 25 pRb, indicating elevated CDK2 activity and an attempt to progress through the cell cycle, 26 although there was a decrease in the fraction of cells with 4N DNA content indicating a 27 deficiency in DNA replication. With 3 M TPA the majority of cells had hypo-pRb with 2N 28 DNA content, consistent with a quiescent state. A small population of cells had hypo-pRb and 29 4N DNA content, suggesting that after DNA replication, the cells entered quiescence without 30 undergoing mitosis, consistent with the CDK2 inc population of cells in Figure 2C that slips back to a CDK2 low state. Combined, these results indicate that Zn 2+ is required for cell cycle 1 progression and there is heterogeneity in the cellular response to Zn 2+ deprivation; some cells are 2 born with low CDK2 activity and immediately enter quiescence, while others are born with 3 elevated CDK2 activity (CDK2 inc ) or increase CDK2 activity after some delay (CDK2 emerge ). 4 Further, our results suggest that the milder the Zn 2+ deficiency, the more cells attempt to progress 5 through the next cell cycle following mitosis. However, there is a clear requirement for Zn 2+ to 6 successfully progress past S-phase to G2/M, which we explore below. 7 8 Timing of Zn 2+ removal with respect to the cell cycle state influences cell fate 9 The experiments in Figure 2 revealed heterogeneity in cell fate in response to Zn 2+ 10 deficiency. Given that the cells were cycling asynchronously prior to Zn 2+ deprivation, we 11 wondered whether the cell fate was determined by a cell's position in the cell cycle at the time of 12 Zn 2+ withdrawal. To address this, we imaged cells expressing the CDK2 sensor in MM for 8 hrs 13 to track cell cycle progression prior to Zn 2+ deprivation and follow entry of cells into quiescence. 14 We binned cell traces according to when cells divided within specific 4 hr windows relative to 15 TPA addition (hr 0), from 4 hrs before TPA addition (-4 to 0) up to 16 hrs after TPA addition 16 ( Figure 3A , gray shaded boxes). For cells that divided within 4 hrs prior to TPA addition, a 17 small but elevated percent of cells went quiescent (15% vs. 7% in MM), suggesting that cells 18 need Zn 2+ when exiting mitosis and progressing into G1. Still, when cells divided within 4 hrs of 19 Zn 2+ deprivation, the majority of cells re-enter the cell cycle either immediately (CDK2 inc ) or 20 with a slight delay (CDK2 emerge ). What was striking about this population of cells, was that only consistent with an inability to progress past S-phase in the absence of Zn 2+ . 3 To more precisely examine the timing of events (Zn 2+ removal, mitosis and cell fate) and 4 compare to the behavior to mitogen removal, we plotted heat maps of individual cell traces over 5 time ( Figure 3B ). We computationally grouped cell traces by their CDK2 activity at the end of 6 the growth period, demonstrating 1) the two major cell fates for ZD cells: quiescence in red and proportion of cells experienced a prolonged low CDK2 activity period (longer red streak) before 13 re-entering the cell cycle. These results suggest that if cells experience a short window of Zn 2+ 14 deficiency they have a greater chance of re-entering the cell cycle; but as the length of time 15 increases, cells experience prolonged bouts of low CDK2 activity, suggesting that Zn 2+ plays a 16 role in processes involved in ramping up CDK2 activity to promote cell cycle entry. In contrast, 17 the majority of cells in MM continued to cycle throughout the measurement window.
18
To compare Zn 2+ deficiency-induced quiescence to mitogen withdrawal, we aligned bottom), our traces reveal that the CDK2 activity window that defines cell cycle commitment 25 with respect to mitogen removal does not apply to Zn 2+ removal. Instead, as other data 26 representations suggest, even if cells pass the restriction point for mitogens, they stall at an 27 intermediate CDK2 activity in the absence of sufficient Zn 2+ , suggesting that Zn 2+ deficiency-28 induced quiescence acts through distinct pathways compared to mitogen withdrawal. 1 Because we found a large population of cells which stalled at an intermediate CDK2 2 activity under Zn 2+ deficient conditions and speculated that these cells were stalled in S phase, 3 we wanted to measure whether these cells were capable of DNA synthesis. We grew cells as in boxes on right plot). In MM and ZR, the Edu vs. DNA content density plot followed a classical 11 arch distribution, as has been found previously for MCF10A in full growth media (45). In ZD 12 conditions, cells did not exhibit high EdU intensity, indicating normal DNA synthesis was 13 impaired, and a large portion of cells were EdUwith 2N DNA content, consistent with 14 quiescence. Interestingly, in ZD conditions, many cells between 2N and 4N DNA content 15 exhibited some Edu staining above that of cells classified as EdU -, suggesting that some cells are 16 able to enter S phase, begin DNA synthesis, but at a reduced rate in the 15 min interval. The EdU 17 intensities for cells grown in 2µM TPA were slightly higher than those for cells grown in 3µM 18 TPA, demonstrating that 2µM TPA is a milder ZD condition and impairment of DNA synthesis 19 was less severe. These data confirm our findings from Figure 3 , where in addition to quiescence, 20 a cell fate with intermediate CDK2 activity exists. This state of intermediate CDK2 activity is 21 indeed S phase, as indicated by cells undergoing DNA synthesis, albeit at a reduced rate. Thus, 22 though these cells have crossed a G1/S transition, Zn 2+ is required in S phase for DNA synthesis 23 to proceed at a normal rate and for cells to complete DNA synthesis and progress to G2/M. 24 25 Zn 2+ deficiency leads to increased levels of DNA damage in cycling cells 26 Cells that experience mild DNA damage can temporarily exit the cell cycle and enter a 27 quiescent state in order to avoid passing a damaged genome on to the next generation. Given 28 that long term (multi-day) growth in Zn 2+ deficient media has previously been shown to increase 29 DNA damage in a population of cells by the comet assay (31-33), we wondered whether mild 30 Zn 2+ deficiency could induce DNA damage on a shorter timescale and whether this DNA damage could be a cause of quiescence induced by Zn 2+ deficiency. Further, because we found 1 that ZD conditions caused a defect in DNA synthesis, we wanted to assess whether cells stalled 2 in S phase were experiencing replication stress. Because we observed heterogeneity in cell cycle 3 fates upon Zn 2+ withdrawal, we sought to measure DNA damage at the single cell level and 4 correlate it with a cell cycle marker. Previously Arora and coworkers determined that whether 5 naturally cycling cells enter quiescence and how long they spend in quiescence is in part 6 explained by levels of double-stranded break (DSB) DNA damage inherited from mother cells, 7 as measured by tracking fluorescent 53BP1 foci (a known marker of DSBs) (42) . Around the 8 same time, Barr and coworkers demonstrated that both DSBs and single strand breaks (SSBs, 9 measured by RPA2 foci) during S phase contribute to induction of quiescence (46) . We used a 10 similar approach, quantifying 53BP1 and RPA2 puncta in individual cells to identify the 11 presence of DSB and SSB, respectively. We correlated DNA damage markers with the cell 12 cycle using phospho-Rb status in hundreds of individual cells exposed to 24 hrs of either ZD, 13 MM, or ZR growth conditions, where cells that were hypo-pRb were classified as quiescent, 14 while hyper-pRb cells were classified as cycling (G1, S, G2 or M). For cells classified as 15 quiescent (hypo-pRb), there was very little difference in 53BP1 foci (DSBs) or RPA2 foci 16 (SSBs) between the different media conditions, although there was a slight increase in cells with 17 DSB in ZD versus MM and ZR media (67% versus 59% and 53%, Figure 5 ). These results 18 suggest that DNA damage is likely not the primary mechanism of induction of quiescence in 19 Zn 2+ deficient cells. However, in cycling cells, there was an increase in 53BP1 foci (84% in ZD 20 versus ~ 50% in MM and ZR) and RPA2 foci (~ 20% in ZD versus < 5% in MM and ZR). DNA DNA damage in quiescent cells, we speculate that the cells with increased DNA damage 26 correspond to the cells stalled in the cell cycle at S phase (Figure 3) , and that Zn 2+ deficiency 27 induces a defect in DNA synthesis (Figure 4 ) that contributes to the inability of these cells to 28 progress to G2/M. Our results also suggest that Zn 2+ deficiency can induce quiescence 29 independent of induction of DNA damage because those cells that have gone quiescent by 24 hrs 30 do not exhibit a profound increase in DNA damage.
Zn 2+ deficiency causes a defect in DNA synthesis

Quiescence induced by Zn 2+ deficiency does not require p21
1 p21 is a cyclin dependent kinase inhibitor that binds to and inhibits the activity of cyclin-2 CDK complexes, thus regulating cell cycle progression. p21 is upregulated in response to 3 contact inhibition and growth factor withdrawal and contributes to cell cycle arrest upon these 4 perturbations (47) . Furthermore, p21 is a transcriptional target of p53 and has been shown to be 5 upregulated in response to DNA damage, which results in cell cycle arrest and presumably 6 enables DNA repair prior to cell cycle re-entry. Thus, p21 has emerged as an important regulator 7 of the proliferation-quiescence decision (19, 46) . This is underscored by the observation that in 8 p21 null cells, the incidence of spontaneous quiescence is reduced (16, 42) . Given that Zn 2+ 9 deficiency influences cell cycle progression by inducing quiescence and that it also results in 10 increased DNA damage, we sought to determine whether quiescence resulting from Zn 2+ 11 deficiency requires p21. We grew WT and p21-/-MCF10A cells expressing the CDK2 reporter 12 and measured the fraction of cells in each classification (CDK2 low/emerge/high ) under ZD, MM, and 13 ZR conditions ( Figure 6A ). In WT cells grown in MM or ZR, 17% or 16% (respectively) of 14 cells were classified as quiescent (CDK2 low ), while in p21-/-cells, only 8% or 5% cells were 15 classified as quiescent, consistent with previous results suggesting that spontaneous quiescence 16 in naturally cycling cells is induced by endogenous DNA damage and is dependent on p21 (42, 17 46). In ZD conditions quiescence occurred at a similar rate in p21-/-and WT cells (42% vs. 18 56%), suggesting that quiescence caused by Zn 2+ deficiency does not explicitly require p21 19 ( Figure 6A ). This is perhaps not surprising, given that the cell population that was quiescent 20 after 24 hrs of growth in Zn 2+ deficient media did not exhibit increased DNA damage ( Figure 5 ). 21 Combined, our data indicate that Zn 2+ -deficiency induces quiescence via a p21-independent 22 pathway. Because p21 is also upregulated to maintain quiescence (15), we measured p21 levels 23 in WT MCF10A cells using immunofluorescence after 40 hrs of growth. In ZD media, cells that 24 maintained low CDK2 activity had higher levels of p21, similar to cells in MM media ( Figure   25 6B). These data suggest that although p21 is not required for entry into quiescence, in WT cells 26 p21 is upregulated when cells are quiescent, likely to maintain their quiescent state by 27 suppressing CDK2 activity. Zn 2+ resupply induces synchronized cell cycle re-entry 1 To determine whether Zn 2+ deficiency-induced quiescence is reversible, we grew cells for 2 24 hrs in ZD media followed by 36 hrs with either MM or ZR media. Zn 2+ resupply caused 3 CDK2 activity to increase and the resumption of mitosis events (red dots), indicating active cell 4 division ( Figure 7A ). It appeared that a smaller subset of cells remained quiescent when rescued 5 with ZR as opposed to when rescued with MM (see CDK2 low traces in highlighted windows in 6 Figure 7A ). To quantify this, we generated CDK2 activity probability density plots for each hr 7 after resupply with either MM or ZR ( Figure 7B and Supplemental Figure 5 ). After 1 hr of Zn 2+ 8 resupply, the majority of cells were quiescent in all three conditions (CDK2 low , activity mean ~ 9 0.5). After 8 hrs of resupply, cells not resupplied (ZD) remained in a CDK2 low state, while 10 resupplied cells emerged from quiescence and entered the cell cycle, as indicated by the cell 11 populations shifting towards higher CDK2 activity, with a mean around 1.25. The ZR resupplied 12 cells had a higher probability of being in this higher CDK2 state and a corresponding lower 13 probability of being in the CDK2 low state compared to cells resupplied with MM, suggesting a 14 positive correlation between the amount of Zn 2+ in the media and cell cycle re-entry after a 15 period of deficiency. 16 
17
Discussion
18
Accurate duplication of the genome and separation of chromosomes into daughter cells 19 through the process of the cell-division cycle is one of the most essential functions individual 20 cells must execute. Regulated exit of the cell cycle to quiescence is an important quality control 21 pathway that reduces metabolic and biochemical activities and protects cells against stress and 22 toxic metabolites (48) . Given the importance of understanding the factors that regulate cell cycle 23 entry, progression, and exit to quiescence, decades of research have sought to define the 24 underlying mechanisms of the proliferation-quiescence 'decision'. Much of our understanding 25 of the mammalian cell cycle has derived from studies in which populations of cells were forced 26 to exit the cell cycle upon induction of stress, such as serum starvation or amino acid deprivation. 27 These studies have revealed many of the key regulators of the cell cycle and introduced the 28 concept of a restriction point, a point at which cells commit to the cell cycle, and become 29 mitogen-independent. However, recent application of single cell technologies for tracking 30 cellular and molecular markers and the fate of individual cells have led to key revisions of the textbook model of the mammalian cell cycle, including the discovery that in naturally cycling 1 cells there are multiple proliferation decisions (14, (16) (17) (18) . Furthermore, it is now appreciated, 2 but still poorly understood that quiescence is not a single dormant state, but rather an assemblage 3 of heterogeneous states, that is actively maintained (14, 15, 49) . Broadly speaking, control of the 4 decision to proliferate or arrest is fundamental to various aspects of tissue architecture 5 maintenance, differentiation, DNA damage repair, wound healing, and normal vs. cancerous cell 6 growth (14, 18, 50) . Thus, understanding how individual triggers act to induce quiescence is 7 important for ultimately identifying targets for improving nutritional deficiencies or disease 8 states. 9 Building on the emerging conceptual framework of studying the cell cycle in 10 asynchronous populations of cells, in this work we apply a combination of fluorescent reporters, 11 high throughput imaging, and quantitative image analysis to revisit the important but unresolved 12 question of how Zn 2+ deficiency blocks cell proliferation. While it has long been recognized that 13 Zn 2+ is required for cell proliferation, how Zn 2+ deficiency influences the cell cycle on a single 14 cell level has not been elucidated and whether Zn 2+ affects the critical proliferation-quiescence 15 cell fate decision has not been determined. Zn 2+ is an essential metal that serves as a critical 16 cofactor in approximately 10% of the proteins encoded by the human genome (51), including 17 over 700 Zn 2+ -finger containing transcription factors, DNA polymerase, superoxide dismutase, 18 and proteins involved in DNA repair (52) . Thus, it is required for several key cellular processes 19 involving these proteins, including processes relevant for the cell cycle such as transcription, 20 antioxidant defense, DNA synthesis and repair. 21 It is often overlooked that in addition to serving as a reservoir for mitogens, serum is also 22 the major source of essential micronutrients including Zn 2+ , Fe 2+ , and Mn 2+ , and thus complete 23 removal of serum also eliminates exogenous supply of these and other essential nutrients. We 24 sought to isolate the effect of Zn 2+ by examining Zn 2+ deprivation in an asynchronous population 25 of cells still containing sufficient mitogen levels. We subjected cells to mild Zn 2+ perturbations 26 that altered the labile pool of cytosolic Zn 2+ between 1 and 210 pM and avoided induction of cell 27 death. Upon Zn 2+ deprivation, cells lost the ability to actively proliferate and the majority 28 experienced one of two cell fates: entry into quiescence or stall in S phase, indicating that unlike 29 mitogens there is not a single restriction point for Zn 2+ , perhaps because it would be too hard to 30 evolve a checkpoint for every nutrient, or perhaps because Zn 2+ is essential for so many cellular processes. Tracking individual cells before and after Zn 2+ deprivation revealed the temporal how rapidly cells sense Zn 2+ deficiency and how consequences of Zn 2+ deficiency, such as 23 increased DNA damage, correlate with cell fate. By following the fate of cells over time in 24 response to Zn 2+ withdrawal, we show that individual cells sense depletion of the labile Zn 2+ 25 pool quickly (within 4 hrs), and that cells in S-phase experience decreased rates of DNA 26 synthesis and increased DNA damage, inducing cell cycle exit, despite these cells having 27 sufficient mitogens to have passed the restriction point.
28
If cells divided > 8 hrs after Zn 2+ withdrawal, the vast majority were born with low 29 CDK2 activity and immediately entered a quiescent state. Intriguingly, these cells didn't exhibit 30 an increase in DNA damage and p21 was not required for entry into this quiescent state, MCF10A cells were obtained from ATCC and maintained in full growth DMEM/F12 media 23 (FGM) supplemented with 5% horse serum, 1% Pen/strep antibiotics, 20 ng/mL EGF, 0.5 g/ml 24 hydrocortisone, 100 ng/ml cholera toxin, and 10 g/ml insulin in a humidified incubator at 37 °C 25 and 5% CO2, as described previously by the Brugge lab (59) . Cells were passaged with trypsin- 26 EDTA. For imaging and growth experiments, cells were grown in 50:50 Ham's F12 phenol red 27 free/FluoroBrite TM DMEM with 1.5% Chelex® 100-treated horse serum, 1% Pen/strep 28 antibiotics, 20 ng/mL EGF, 0.5 g/ml hydrocortisone, 100 ng/ml cholera toxin, and 10 g/ml 29 Chelex® 100-treated insulin. Chelex® 100 was used to chelate excess Zn 2+ from horse serum 30 and insulin to generate the defined minimal media (MM). ZR media was generated by supplementing MM with 30 µM ZnCl2 and ZD media was generated by adding 2-3 µM TPA. 1 Cell lines were routinely tested and confirmed to be mycoplasma negative by PCR. (ppb) to the known amount of Y or Ga (ppb). The Zn 2+ ion counts were then converted to ppb 10 using a Zn 2+ standard curve. Samples were submitted for ICP-MS analysis to the LEGS Lab at 11 CU Boulder. 12 13 Plasmids and cell lines 14 MCF10A cell lines expressing PB-NES ZapCV2 (41) and PB-H2B-mCherry were generated 15 using the PiggyBac™ Transposon system via electroporation-mediated transfection. Stable cell 16 lines used for long-term imaging were generated with G418 and puromycin antibiotic selection 17 followed by FACS enrichment of dual positive fluorescent cells. The MCF10A cell line stably 18 expressing DHB-Venus (CDK2 sensor) and H2B-mTurquoise2 and the MCF10A p21-/-were 19 provided by the laboratory of Dr. Sabrina Spencer, CU Boulder, and generated as described 20 previously (16) . Validation of p21 knockout in this cell line was performed using 21 immunofluorescence with a p21 antibody, as described below (See Supplemental Figure 6 ). 22 23 Live cell imaging 24 Cells were counted with a Countess TM II Automated Cell Counter (Thermo Fisher Scientific, 25 Waltham, MA) and plated at a density of 2,500-3,500 cells/well ~24 hrs before imaging in 26 minimal media in glass bottom 96-well plates (P96-1.5H-N, Cellvis, Mountain View, CA). This 27 starting density was chosen to avoid significant contact inhibition during the imaging period. In 28 Figure 1 , 2, and 5, cells were plated in 100 µL MM and 2x media of each specific nutritional 29 regime (ZD, MM, ZR) was added immediately prior to imaging. In Figure 3 , cells were plated in 30 100 µL MM and 2x ZD media was added after 8 hrs. In Figure 7 , cells were plated in 100 µL, 2x media of specified conditions was added immediately prior to imaging; after 24 hrs, 100 µL of 1 media was removed, and 2x media of specified conditions was resupplied. Images were 2 collected using a Nikon Ti-E inverted microscope microscope with a Lumencor SPECTRA X Cell pellets were washed with PBS, fixed with 4% paraformaldehyde and permeabilized with 25 methanol at -20 °C. Cells were stained for one hr with Phospho-Rb Ser 807/811 (D20B12 XP ® , 26 Cell Signaling Technology, Danvers, MA) at 1:500 dilution prior to Alexa Fluor TM 488 27 secondary antibody (ab150073, Abcam, Cambrdige, MA) staining at 1:500 dilution for one hr.
Antibodies were diluted in PBST with 1% BSA. PI DNA staining was performed using 29 FxCycle TM PI/RNAse (Thermo Fisher Scientific F10797). FACS for phospho-Rb and PI was 30 performed on a BD FACSCelesta TM instrument and analyzed with BD FACSDiva TM v8 software combination of adaptive thresholding and the watershed algorithm to segment clumps of cells. 23 The nuclear mask was used to calculate the mean nuclear pRB or p21 intensities for each cell. 24 For cells containing the CDK2 sensor, the nuclear mask was used to draw a ring 3 pixels wide 25 around the nucleus for computing the CDK2 activity (defined as the ratio of cytoplasmic 26 intensity / nuclear intensity) of the cell. For DNA damage experiments, the centroid of each cell 27 (as defined by the nuclear mask) was used to construct a 140 x 140 pixel square around each cell; 28 this enabled the use of MATLABs 'adaptthresh' function for constructing an accurate foci mask 29 for each cell. The foci mask was further refined by filtering out any objects that were not the 30 appropriate size (area 10-100 px 2 for RPA2 and 10-200 px 2 for 53BP1) or shape (eccentricity < exposure) every 30 seconds for several mins. To collect Rmin, 50µM TPA in MM was added and 23 cells were again imaged for several mins. Cells were then washed three times with phosphate, 24 calcium, and magnesium free HEPES-buffered HBSS, pH 7.4, for removal of TPA. Finally, for 25 collection of Rmax, cells were treated with this HBSS buffer with 119 nM buffered Zn 2+ solution, 26 0.001% saponin, and 5 µM pyrithione, as previously described (60) . Average Rrest and Rmin were In Figure 1A , FRET ratios between cells grown under ZD, MM, or ZR were compared using 9 One-way ANOVA with post-hoc Tukey HSD, performed using KaleidaGraph v4.02. Alpha was whiskers extend to the most extreme data points, excluding outliers, which are plotted 13 individually with + marks. 14 
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